Live Quote · NASDAQSYREHealthcare· Biotechnology

Spyre Therapeutics, Inc.

$93.47▼ 4.26%($-4.16)
MKT CAP $8.88BNEXT EARNINGS Feb 18, 2027
50%
Bullish
TickerSpark Score
67/100
▌ Solid
55
Valuation
35
Profitability
60
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SYRE research report →

Analyst Price Target
$121.50+30.0% vs. today

Range $115 – $130

Analyst RatingBuy
12 Buy1 Hold0 Sell

Price Chart

+298.25% · this period
$109.00$66.23$23.47Nov 20May 26Nov 20
52-Week Range80% of range
Low
$23.01
Current
$93.47
High
$110.64